STEROFUNDIN Solution for infusion Ref.[28263] Active ingredients: Calcium chloride Magnesium chloride Malic acid Potassium chloride Sodium acetate Sodium chloride

Source: Heads of Medicines Agencies (EU)  Revision Year: 2018  Publisher: B. Braun Melsungen AG, Carl-Braun-StraรŸe 1, 34212 Melsungen, Germany, Phone: +49 5661 71 0, Fax: +49 5661 71 4567

5.1. Pharmacodynamic properties

Pharmacotherapeutic group: Solutions affecting the electrolyte balance, electrolytes
ATC code: B05BB01

This medicinal product is an isotonic electrolyte solution with electrolyte concentrations adapted to plasma electrolyte concentrations. It is used to correct extracellular fluid losses (i.e. losses of water and electrolytes in proportional amounts). The supply of the solution is aimed to restore as well as maintain normal osmotic conditions in the extracellular and intracellular space.

The anion pattern represents a balanced combination of chloride, acetate, and malate which counteracts metabolic acidosis.

5.2. Pharmacokinetic properties

Absorption

Since the ingredients of Sterofundin ISO are infused intravenously their bioavailability is 100%.

Distribution and Elimination

Sodium and chloride mainly distribute in the extracellular space, whereas the preferential distribution of potassium, magnesium and calcium is intracellular. The kidneys are the main route of excretion for sodium, potassium, magnesium, and chloride but small amounts are lost via the skin and intestinal tract. Calcium is excreted in approximately equal amounts in urine and endogenous intestinal secretion.

During the infusion of acetate and malate, their plasma levels rise and appear to reach a steady state. Following termination of the infusion, the acetate and malate concentrations rapidly diminish. Acetate and malate excretion in urine rises during the infusion. However, their metabolism by body tissues is so rapid that only a small fraction appears in urine.

5.3. Preclinical safety data

No preclinical studies have been conducted with Sterofundin ISO. There are no data of relevance to the prescriber additional to those already included elsewhere in the SPC.

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.